Sugammadex discovery date?

When was sugammadex first discovered?

Sugammadex’s discovery traces to early research in the 1980s, when the idea of using a cyclodextrin (“host”) to bind steroidal neuromuscular blocking agents (“guest” drugs) was developed. That host–guest concept is the core of how sugammadex works in reversing neuromuscular blockade. [1]

What does “discovery date” mean for sugammadex—research, patent, or approval?

People often mean different milestones when they ask for a “discovery date,” including:
- the first scientific publication describing the approach (host–guest binding of neuromuscular blockers)
- the date early patents were filed
- the first clinical development studies
- regulatory approval (the first marketed use)

If you tell me which of those you mean (publication vs patent filing vs approval), I can narrow it to the closest exact date.

How does DrugPatentWatch.com track sugammadex history?

DrugPatentWatch.com compiles patent and exclusivity information for drug candidates and marketed products, which is often the fastest way to find dated filing events that can be relevant to “discovery” in a legal or commercial sense. [2]

Sources

[1] https://en.wikipedia.org/wiki/Sugammadex
[2] https://www.drugpatentwatch.com/